Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
63.00    0.00 (0.00%)
Bid:
59.00
Ask:
63.00
Spread: 4.00 (6.78%)
Market Cap: £51.30m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Trading Update

19 Jan 2015 07:00

RNS Number : 4722C
Flowtech Fluidpower PLC
19 January 2015
 

 

 

Issued on behalf of Flowtech Fluidpower PLC

Date: Monday, 19 January 2015

Immediate Release

 

 

 

 

 

 

FLOWTECH FLUIDPOWER PLC

("Flowtech" or the "Group")

Trading update

 

The Board of Flowtech issues the following update ahead of the Group's annual financial results for the year ended 31 December 2014:

 

The business has performed in line with consensus Profit Before Tax market expectations for the period ended 31 December 2014*, with growth in both revenue and operating profit and margins being maintained. The Balance Sheet at 31 December 2014 remained lowly geared with net debt expected to be £6.70m.

 

Primary Fluid Power, which was purchased by the Group in August 2014, has continued to trade at expected levels and both operational and commercial integration plans are progressing as envisaged at the time of the acquisition.

 

The Board views the future with confidence and is optimistic that it can continue to grow the business both organically and by acquisition as opportunities arise.

 

The Directors look forward to reviewing the Group's overall performance in more detail at the time of the preliminary results, which are scheduled to be released on Tuesday, 14 April 2015.

 

 

*Consensus market expectations for Profit Before Tax, pre exceptionals,

for the year ended 31 December 2014 are £5.95m

 

Enquiries:

Flowtech Fluidpower plc

AIM: FLO

Sean Fennon, Chief Executive Officer

Bryce Brooks, Chief Financial Officer

Tel: +44 (0) 1695 52796

Email: info@flowtechfluidpower.com

www.flowtechfluidpower.com

Zeus Capital Limited

(Nominated Adviser and Broker)

Ross Andrews, Dominic King, John Treacy

Tel: +44 (0) 207 533 7727

TooleyStreet Communications

(IR and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

Editors' note:

Flowtech, founded in 1983, is the UK's leading specialist supplier of technical fluid power products with modern distribution facilities in the UK and Benelux. It offers an unrivalled range of Original Equipment Manufacturer (OEM) and Own Brand products to c 3,000 distributors and resellers. Its catalogue is recognised as the definitive source for fluid power products, containing approximately 47,000 individual product line and is distributed to more than 90,000 industrial Maintenance, Repair and Overhaul end users (MRO). Over 80% of product is stocked and if ordered by 10pm, can be delivered next day in the UK, providing 'best in industry' service offering. The Group's headquarters and main distribution centre is in Skelmersdale, Lancashire with further centres in the Netherlands and China; in total the business employs 203 people.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFEESAFISEEF
Date   Source Headline
20th May 20247:00 amRNSExercise of Options and Total Voting Rights
17th May 20242:54 pmRNSNotice of AGM
9th May 20247:00 amRNSAnnual Financial Report
1st May 20247:00 amRNSHolding(s) in Company
18th Apr 20244:10 pmRNSDirector/PDMR Shareholding
27th Mar 20242:28 pmRNSClarification note regarding Dividend - REPLACE
26th Mar 20247:16 amRNS2023 Annual Unaudited Results
25th Mar 202411:44 amRNSNotice of Results
1st Feb 202410:38 amRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSTrading update
19th Dec 20237:00 amRNSHolding(s) in Company
25th Oct 202311:42 amRNSHolding(s) in Company
31st Aug 20234:25 pmRNSBoard Update
31st Aug 20237:00 amRNSPDMRs - Director Dealings
30th Aug 20237:00 amRNS2023 Half-year report
31st Jul 20237:00 amRNSTrading update & Notice of Half-year results
13th Jun 20231:42 pmRNSResult of AGM
5th Jun 20237:00 amRNSAwards under Long-Term Incentive Plan
5th Jun 20237:00 amRNSBoard update
19th May 20237:00 amRNSAvailability of Documents & Notice of 2023 AGM
15th May 20237:00 amRNSDirector Dealing
26th Apr 20237:01 amRNSAudited Annual Financial Report FY2022
12th Apr 20237:00 amRNSDirectorate Change
12th Apr 20237:00 amRNSUnaudited Preliminary Results-year ended 31.12.22
24th Mar 20237:00 amRNSNotice of Results - revised date
9th Mar 20238:00 amRNSAnnual Results and Presentation via IMC Platform
26th Jan 20237:00 amRNSTrading Update and Notice of Results
11th Jan 20237:00 amRNSBoard changes: NED Appointment & NED Retirement
21st Dec 20224:39 pmRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report - six months ended 30 June 2022
8th Aug 20226:27 pmRNSHolding(s) in Company
4th Aug 20227:30 amRNS2022 Half-Year Results - Investor Presentation
1st Aug 20227:00 amRNSGroup Trading Update & Notice of HY1 2022 results
21st Jul 20221:03 pmRNSHolding(s) in Company
1st Jun 20222:23 pmRNSResult of AGM and Total Voting Rights
18th May 20227:00 amRNSDirector/PDMR Shareholding
5th May 20222:20 pmRNS2021 Annual Report & Notice of 2022 AGM
3rd May 20227:00 amRNSGrant of Options under Long-Term Incentive Plan
30th Mar 20221:21 pmRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFY2021 Results & publication of the Annual Report
25th Mar 20225:36 pmRNSHolding(s) in Company
7th Mar 20229:00 amRNSNotice of Results and Investor Presentation
21st Feb 20225:49 pmRNSHolding(s) in Company
26th Jan 20227:01 amRNSTrading Statement
26th Jan 20227:00 amRNSAppointment of Nominated Adviser and Sole Broker
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202112:58 pmRNSHolding(s) in Company
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.